Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size


 
Table of Contents   
LETTER TO THE EDITOR
Year : 2019  |  Volume : 14  |  Issue : 1  |  Page : 99
Bone marrow micrometastasis in nonsmall cell lung cancer: A new prognostic marker?


1 Department of Thoracic Surgery, Theagenio Cancer Hospital, Thessaloniki, Greece
2 Department of 1st Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece

Date of Web Publication10-Jan-2019

Correspondence Address:
Nikolaos Barbetakis
Department of Thoracic Surgery, Theagenio Cancer Hospital, Thessaloniki
Greece
Login to access the Email id


DOI: 10.4103/atm.ATM_225_18

Rights and Permissions



How to cite this article:
Barbetakis N, Paliouras D, Diamantopoulos N. Bone marrow micrometastasis in nonsmall cell lung cancer: A new prognostic marker?. Ann Thorac Med 2019;14:99

How to cite this URL:
Barbetakis N, Paliouras D, Diamantopoulos N. Bone marrow micrometastasis in nonsmall cell lung cancer: A new prognostic marker?. Ann Thorac Med [serial online] 2019 [cited 2019 Jan 23];14:99. Available from: http://www.thoracicmedicine.org/text.asp?2019/14/1/99/249802


Sir,

We have read with great interest the article by Jazieh et al.,[1] and we have to congratulate them for their excellent work. The aim of our brief comment is to highlight the significance of molecular detection of isolated tumor cell in the bone marrow. This is highly associated with two findings, poor overall survival (OS) and an increased risk of disease recurrence.[2] It has to be mentioned that the presence of bone marrow micrometastasis in nonsmall cell lung cancer (NSCLC) is not associated with pathological types and tumor staging. Occult bone marrow invasion may represent a new prognostic marker in NSCLC and may help oncologists for the selection of patients for adjuvant therapy following surgery, or to avoid unnecessary operations.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Jazieh AM, AlSumai TS, Ali YZ, Sheblaq NR, Alkaiyat M. The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study. Ann Thorac Med 2018;13:150-5.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Deng XF, Liu QX, Zhou D, Min JX, Dai JG. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: A meta-analysis. Interact Cardiovasc Thorac Surg 2015;21:21-7.  Back to cited text no. 2
    




 

Top
Print this article  Email this article
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (283 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed34    
    Printed0    
    Emailed0    
    PDF Downloaded17    
    Comments [Add]    

Recommend this journal